- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ADAC secures Japanese clearances
Regulatory clearances obtained in late September will enable Sumitomo Metal Industries, the exclusive sales agent for ADACLaboratories in Japan, to begin selling several dual-head gammacameras designated for export to Japan by the Milpitas, CA, company.
Regulatory clearances obtained in late September will enable Sumitomo Metal Industries, the exclusive sales agent for ADACLaboratories in Japan, to begin selling several dual-head gammacameras designated for export to Japan by the Milpitas, CA, company.
The Japanese Ministry of Health and Welfare approved applicationsfor ADAC's Vertex Plus, Solus, and Cardio nuclear imaging systems.The ministry also cleared Molecular Coincidence Detection, ADAC'shigh-energy imaging technique.
Vertex Plus is ADAC's premium variable-angle camera, Solusis a fixed 180° dual-head optimized for oncology, and Cardiois a fixed 90° dual-head system devoted to cardiology.
The approval of MCD was the first of its kind for a high-energyimaging system in Japan, according to ADAC officials. ADAC's optionalMCD feature enables Vertex and Solus gamma cameras to performcoincidence-based fluorodeoxyglucose (FDG) imaging with a SPECTcamera.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
